NDATRANSDERMALFILM, EXTENDED RELEASE
Approved
Sep 2008
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
12
Mechanism of Action
Serotonin 3 Receptor Antagonists
Pharmacologic Class:
Serotonin-3 Receptor Antagonist
Clinical Trials (5)
Study to Assess Bioequivalence and Adhesion Properties Between Two Granisetron Transdermal Patches.
Started Jul 2021
134 enrolled
Healthy Volunteers
Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting
Started Aug 2020
Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis
Started Jan 2019
0Gastroparesis
A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC
Started Mar 2014
A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin
Started Jul 2011